Refine Search
(24)
(319)
(846)
(1727)

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – France”. The report is an essential source of information and analysis on the healthcare, regulato...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”. The report is an essential source of information and analysis on the healthcare, regulator...

NEW Asthma and Chronic Obstructive Pulmonary Disease: Asthma Ahead of COPD in Terms of Innovation with the Focus on Targeted Biologic Therapies for Severe Disease Phenotypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

Asthma and COPD are both highly prevalent, chronic, inflammatory diseases of the airways and lungs. The asthma market is highly saturated with relatively efficacious standard therapies and the COPD market is also highly saturated with therapies...

NEW Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

The pain therapeutics market has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and mechanisms of ac...

NEW Biomarkers in the Central Nervous System

  • $7,995
  • April 2019
Add to Basket Quick View Add to Saved List

Biomarkers in CNS are expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in technologies, and potential of these biomarkers that can...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018

  • $1,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) a...

Global Risk Report Quarterly Update: Q4 2018

  • $1,100
  • March 2019
Add to Basket Quick View Add to Saved List

Global Risk Report is based on GlobalData Country Risk Index (GCRI) which is a unique country risk-rating model that determines the existing and future level of country risk by assessing various qualitative and quantitative factors. The index i...

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. Significant improvements in progression-free survival and overall survival arrived ...

Multiple Myeloma: Epidemiology Forecast to 2027

  • $3,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, ...

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a natural process known as remodeling, some of the bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporo...

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD) is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerul...

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in the scarring of lung tissue and changes the lung’s ability to function normally. The most common signs and symptoms of idiopathic pulmonary fibrosis are dyspnea and a ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • $1,995
  • March 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulat...

Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease

  • $6,995
  • March 2019
Add to Basket Quick View Add to Saved List

The burden of disease associated with gastrointestinal disorders is considerable with many of these disorders being highly prevalent. Additionally, many GI disorders are chronic in nature and are associated with significant impairments in quali...

Brexit and the Healthcare Industry Implications for Pharma – the Story so Far

  • $500
  • March 2019
Add to Basket Quick View Add to Saved List

It may take up to five years for the healthcare industry to stabilize in the event of a ‘no deal’ Brexit. This is the consensus opinion among professionals surveyed in the pharmaceutical industry, according to GlobalData, a leading data and ana...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India

  • $1,995
  • February 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India”. The report is an essential source of information and analysis on the healthcare, regulator...

Chimeric Antigen Receptor Cell Therapy

  • $7,995
  • February 2019
Add to Basket Quick View Add to Saved List

Chimeric antigen receptor (CAR) cell therapy is an immuno-oncology (IO) approach that has gained increasing momentum in the past few years, with the approval of two new therapies in 2017 (US) and 2018 (EU). Novartis’ Kymriah (tisagenlecleucel) ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

  • $1,995
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information and analysis on the healthcare, regulator...

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

The State of the Microbiome

  • $1,495
  • January 2019
Add to Basket Quick View Add to Saved List

This report provides an assessment of how the pharmaceutical industry perceives the state of the microbiome, including the challenges associated with developing, launching, and manufacturing microbiome therapeutics as well as where opportunity ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018

  • $1,500
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK

  • $1,995
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK”. The report is an essential source of information and analysis on the healthcare, regulatory a...

Psoriatic Arthritis: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriatic arthritis is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and sacroiliac joints of the pelvis. Up to 30% of...

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Plaque Psoriasis: Epidemiology Forecast to 2027

  • $3,995
  • December 2018
Add to Basket Quick View Add to Saved List

Plaque psoriasis is a chronic immune-mediated skin disease characterized by red, flaky patches that are itchy and sometimes painful. Psoriatic plaques are formed due to an increased production of skin cells; normally the process to make and rep...

Age-Related Macular Degeneration: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Age-Related macular degeneration (AMD) is one of the leading cause of vision loss among people ages 50 and over in the developed world, characterized by the deterioration or breakdown of the macula, a small area of the central retina needed for...

Glaucoma: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people...

Cloud Computing in Healthcare - Thematic Research

  • $1,950
  • December 2018
Add to Basket Quick View Add to Saved List

Cloud computing (including IaaS, PaaS, SaaS, private, and hybrid cloud services, managed cloud services and cloud management platforms) accounted for 7.6% of a global information and communications technology (ICT) market that was worth $3 tril...

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule, immunogenic drugs produced from living cells. “Innovator” biologics are the first to be approved, and when their patent protection...

Contraceptives: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions, particularly menstrual-related disorders. This report focuses on ...

Biomarkers and Companion Diagnostics in Oncology

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patient’s disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine development. As outbreaks of Ebola virus, Zika virus, and other EIDs have occurred in the past decade...

Neuroimmunology Drug Development

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Neuroimmunology is expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in neurogenetics, and potential of these drugs that can contri...

Partnerships, Licensing, Investments and M&A Deals and Trends for September 2018 in Pharmaceuticals

  • $1,000
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for September 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) ...

Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals

  • $1,000
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

Botulism Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Botulism Global Clinical Trials Review, H2, 2018" provides an overview of Botulism clinical trials scenario. This report provides top line data relating to the clinical trials on Botulism. Report in...

Bradycardia Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bradycardia Global Clinical Trials Review, H2, 2018" provides an overview of Bradycardia clinical trials scenario. This report provides top line data relating to the clinical trials on Bradycardia. ...

Brain Cancer Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cance...

Brain (Head) Trauma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain (Head) Trauma Global Clinical Trials Review, H2, 2018" provides an overview of Brain (Head) Trauma clinical trials scenario. This report provides top line data relating to the clinical trials ...

Brain Hemorrhage Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2018" provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Bra...

Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018" provides an overview of Branch Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to ...

Brenner Tumor Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H2, 2018" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner T...

Bronchiectasis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchi...

Bronchiolitis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchiolitis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiol...

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiolitis Obliterans clinical trials scenario. This report provides top line data relating to the clinic...

Bronchitis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Rep...

Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018" provides an overview of Bronchopulmonary Dysplasia clinical trials scenario. This report provides top line data relating to the cl...

Bronchospasm Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H2, 2018" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospas...

Brucellosis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2018" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. ...

Bruise (Contusion) Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bruise (Contusion) Global Clinical Trials Review, H2, 2018" provides an overview of Bruise (Contusion) clinical trials scenario. This report provides top line data relating to the clinical trials on...

Bulimia Nervosa Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bulimia Nervosa Global Clinical Trials Review, H2, 2018" provides an overview of Bulimia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Bulim...

Bullous Pemphigoid Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bullous Pemphigoid Global Clinical Trials Review, H2, 2018" provides an overview of Bullous Pemphigoid clinical trials scenario. This report provides top line data relating to the clinical trials on...

Burkitt Lymphoma Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Bur...

Burns Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Burns Global Clinical Trials Review, H2, 2018" provides an overview of Burns clinical trials scenario. This report provides top line data relating to the clinical trials on Burns. Report includes an...

Cachexia Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H2, 2018" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report in...

Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cancer Anorexia-Cachexia Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Cancer Anorexia-Cachexia Syndrome clinical trials scenario. This report provides top line data rela...

Cancer Pain Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H2, 2018" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. ...

Candidiasis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H2, 2018" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. ...

Cardiac Arrest Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, H2, 2018" provides an overview of Cardiac Arrest clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiac...

Cardiogenic Shock Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiogenic Shock Global Clinical Trials Review, H2, 2018" provides an overview of Cardiogenic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on C...

Cardiometabolic Disease Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H2, 2018" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical...

Cardiomyopathy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiomyopathy Global Clinical Trials Review, H2, 2018" provides an overview of Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiom...

Cardiovascular Inflammation Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H2, 2018" provides an overview of Cardiovascular Inflammation clinical trials scenario. This report provides top line data relating to the ...

Caries Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Caries Global Clinical Trials Review, H2, 2018" provides an overview of Caries clinical trials scenario. This report provides top line data relating to the clinical trials on Caries. Report includes...

Carotid Artery Stenosis Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Carotid Artery Stenosis Global Clinical Trials Review, H2, 2018" provides an overview of Carotid Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical...

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on...

Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Carpal Tunnel Syndrome clinical trials scenario. This report provides top line data relating to the clinical t...

Cat Allergy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cat Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Cat Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cat Allergy. ...

Cataract Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H2, 2018" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report in...

Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Infarction (Brain Infarction) clinical trials scenario. This report provides top line...

Celiac Disease Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, H2, 2018" provides an overview of Celiac Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Celiac ...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks